Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Celgene Corp. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

This company was transferred to the archive: financial data is no longer updated!

Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)


Analysis of Liquidity Ratios

Beginner level


Liquidity Ratios (Summary)

Celgene Corp., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Current ratio hidden hidden hidden hidden hidden
Quick ratio hidden hidden hidden hidden hidden
Cash ratio hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.’s current ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.’s quick ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.’s cash ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Current Ratio

Celgene Corp., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Current assets hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Liquidity Ratio
Current ratio1 hidden hidden hidden hidden hidden
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Current Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Current Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

1 2018 Calculation
Current ratio = Current assets ÷ Current liabilities
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.’s current ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Quick Ratio

Celgene Corp., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Cash and cash equivalents hidden hidden hidden hidden hidden
Debt securities available-for-sale hidden hidden hidden hidden hidden
Equity investments with readily determinable fair values hidden hidden hidden hidden hidden
Marketable securities available-for-sale hidden hidden hidden hidden hidden
Accounts receivable, net of allowances hidden hidden hidden hidden hidden
Total quick assets hidden hidden hidden hidden hidden
 
Current liabilities hidden hidden hidden hidden hidden
Liquidity Ratio
Quick ratio1 hidden hidden hidden hidden hidden
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Quick Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Quick Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

1 2018 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.’s quick ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Cash Ratio

Celgene Corp., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Cash and cash equivalents hidden hidden hidden hidden hidden
Debt securities available-for-sale hidden hidden hidden hidden hidden
Equity investments with readily determinable fair values hidden hidden hidden hidden hidden
Marketable securities available-for-sale hidden hidden hidden hidden hidden
Total cash assets hidden hidden hidden hidden hidden
 
Current liabilities hidden hidden hidden hidden hidden
Liquidity Ratio
Cash ratio1 hidden hidden hidden hidden hidden
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Cash Ratio, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Cash Ratio, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

1 2018 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.’s cash ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.